Skip to main content
Top
Published in: BMC Medicine 1/2022

Open Access 01-12-2022 | Malaria | Research article

Gravidity and malaria trends interact to modify P. falciparum densities and detectability in pregnancy: a 3-year prospective multi-site observational study

Authors: Glória Matambisso, Nanna Brokhattingen, Sónia Maculuve, Pau Cisteró, Henriques Mbeve, Anna Escoda, Judice Miguel, Elena Buetas, Ianthe de Jong, Boaventura Cuna, Cardoso Melembe, Nelo Ndimande, Gemma Porras, Haily Chen, Kevin K. A. Tetteh, Chris Drakeley, Benoit Gamain, Chetan Chitnis, Virander Chauhan, Llorenç Quintó, Beatriz Galatas, Eusébio Macete, Alfredo Mayor

Published in: BMC Medicine | Issue 1/2022

Login to get access

Abstract

Background

Low-density Plasmodium falciparum infections prevail in low transmission settings, where immunity is expected to be minimal, suggesting an immune-independent effect on parasite densities. We aimed to describe parasite densities in pregnancy, and determine how gravidity and antibody-mediated immunity affect these, during a period of declining malaria transmission in southern Mozambique.

Methods

We documented P. falciparum infections at first antenatal care visits (n = 6471) between November 2016 and October 2019 in Ilha Josina (high-to-moderate transmission area), Manhiça (low transmission area), and Magude (pre-elimination area). Two-way interactions in mixed-effects regression models were used to assess gravidity-dependent differences in quantitative PCR-determined P. falciparum positivity rates (PfPRqPCR) and densities, in the relative proportion of detectable infections (pDi) with current diagnostic tests (≥ 100 parasites/μL) and in antimalarial antibodies.

Results

PfPRqPCR declined from 28 to 13% in Ilha Josina and from 5–7 to 2% in Magude and Manhiça. In primigravidae, pDi was highest in Ilha Josina at the first study year (p = 0.048), which declined with falling PfPRqPCR (relative change/year: 0.41, 95% CI [0.08; 0.73], p = 0.029), with no differences in antibody levels. Higher parasite densities in primigravidae from Ilha Josina during the first year were accompanied by a larger reduction of maternal hemoglobin levels (− 1.60, 95% CI [− 2.49; − 0.72; p < 0.001), than in Magude (− 0.76, 95% CI [− 1.51; − 0.01]; p = 0.047) and Manhiça (− 0.44, 95% CI [− 0.99; 0.10; p = 0.112). In contrast, multigravidae during the transmission peak in Ilha Josina carried the lowest pDi (p = 0.049). As PfPRqPCR declined, geometric mean of parasite densities increased (4.63, 95% CI [1.28; 16.82], p = 0.020), and antibody levels declined among secundigravidae from Ilha Josina.

Conclusions

The proportion of detectable and clinically relevant infections is the highest in primigravid women from high-to-moderate transmission settings and decreases with declining malaria. In contrast, the falling malaria trends are accompanied by increased parasite densities and reduced humoral immunity among secundigravidae. Factors other than acquired immunity thus emerge as potentially important for producing less detectable infections among primigravidae during marked declines in malaria transmission.
Appendix
Available only for authorised users
Literature
1.
go back to reference Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.CrossRefPubMed Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.CrossRefPubMed
2.
go back to reference Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32.CrossRefPubMed Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32.CrossRefPubMed
4.
go back to reference Rono MK, Nyonda MA, Simam JJ, Ngoi JM, Mok S, Kortok MM, Abdullah AS, Elfaki MM, Waitumbi JN, El-Hassan IM, et al. Adaptation of Plasmodium falciparum to its transmission environment. Nat Ecol Evol. 2018;2(2):377–87.CrossRefPubMed Rono MK, Nyonda MA, Simam JJ, Ngoi JM, Mok S, Kortok MM, Abdullah AS, Elfaki MM, Waitumbi JN, El-Hassan IM, et al. Adaptation of Plasmodium falciparum to its transmission environment. Nat Ecol Evol. 2018;2(2):377–87.CrossRefPubMed
5.
go back to reference Andrade CM, Fleckenstein H, Thomson-Luque R, Doumbo S, Lima NF, Anderson C, Hibbert J, Hopp CS, Tran TM, Li S, et al. Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season. Nat Med. 2020;26(12):1929–40.CrossRefPubMed Andrade CM, Fleckenstein H, Thomson-Luque R, Doumbo S, Lima NF, Anderson C, Hibbert J, Hopp CS, Tran TM, Li S, et al. Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season. Nat Med. 2020;26(12):1929–40.CrossRefPubMed
6.
go back to reference Mancio-Silva L, Slavic K, Grilo Ruivo MT, Grosso AR, Modrzynska KK, Vera IM, Sales-Dias J, Gomes AR, MacPherson CR, Crozet P, et al. Nutrient sensing modulates malaria parasite virulence. Nature. 2017;547(7662):213–6.CrossRefPubMedPubMedCentral Mancio-Silva L, Slavic K, Grilo Ruivo MT, Grosso AR, Modrzynska KK, Vera IM, Sales-Dias J, Gomes AR, MacPherson CR, Crozet P, et al. Nutrient sensing modulates malaria parasite virulence. Nature. 2017;547(7662):213–6.CrossRefPubMedPubMedCentral
7.
go back to reference Nkumama IN, O’Meara WP, Osier FHA. Changes in malaria epidemiology in Africa and new challenges for elimination. Trends Parasitol. 2017;33(2):128–40.CrossRefPubMed Nkumama IN, O’Meara WP, Osier FHA. Changes in malaria epidemiology in Africa and new challenges for elimination. Trends Parasitol. 2017;33(2):128–40.CrossRefPubMed
9.
go back to reference Walker PG, Griffin JT, Cairns M, Rogerson SJ, van Eijk AM, ter Kuile F, Ghani AC. A model of parity-dependent immunity to placental malaria. Nat Commun. 2013;4:1609.CrossRefPubMed Walker PG, Griffin JT, Cairns M, Rogerson SJ, van Eijk AM, ter Kuile F, Ghani AC. A model of parity-dependent immunity to placental malaria. Nat Commun. 2013;4:1609.CrossRefPubMed
10.
go back to reference Tuikue Ndam N, Tornyigah B, Dossou AY, Escriou G, Nielsen MA, Salanti A, Issifou S, Massougbodji A, Chippaux JP, Deloron P. Persistent Plasmodium falciparum infection in women with an intent to become pregnant as a risk factor for pregnancy-associated malaria. Clin Infect Dis. 2018;67(12):1890–6.PubMed Tuikue Ndam N, Tornyigah B, Dossou AY, Escriou G, Nielsen MA, Salanti A, Issifou S, Massougbodji A, Chippaux JP, Deloron P. Persistent Plasmodium falciparum infection in women with an intent to become pregnant as a risk factor for pregnancy-associated malaria. Clin Infect Dis. 2018;67(12):1890–6.PubMed
11.
go back to reference Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18(4):e107–18.CrossRefPubMed Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18(4):e107–18.CrossRefPubMed
12.
go back to reference Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 2003;49(1):179–91.CrossRefPubMed Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 2003;49(1):179–91.CrossRefPubMed
13.
go back to reference Galatas B, Guinovart C, Bassat Q, Aponte JJ, Nhamussua L, Macete E, Saute F, Alonso P, Aide P. A prospective cohort study to assess the micro-epidemiology of Plasmodium falciparum clinical malaria in Ilha Josina Machel (Manhica, Mozambique). Malar J. 2016;15(1):444.CrossRefPubMedPubMedCentral Galatas B, Guinovart C, Bassat Q, Aponte JJ, Nhamussua L, Macete E, Saute F, Alonso P, Aide P. A prospective cohort study to assess the micro-epidemiology of Plasmodium falciparum clinical malaria in Ilha Josina Machel (Manhica, Mozambique). Malar J. 2016;15(1):444.CrossRefPubMedPubMedCentral
14.
go back to reference Galatas B, Saute F, Marti-Soler H, Guinovart C, Nhamussua L, Simone W, Munguambe H, Hamido C, Montana J, Muguande O, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study. PLoS Med. 2020;17(8):e1003227.CrossRefPubMedPubMedCentral Galatas B, Saute F, Marti-Soler H, Guinovart C, Nhamussua L, Simone W, Munguambe H, Hamido C, Montana J, Muguande O, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study. PLoS Med. 2020;17(8):e1003227.CrossRefPubMedPubMedCentral
15.
go back to reference Galatas B, Mayor A, Gupta H, Balanza N, Jang IK, Nhamussua L, Simone W, Cistero P, Chidimatembue A, Munguambe H, et al. Field performance of ultrasensitive and conventional malaria rapid diagnostic tests in southern Mozambique. Malar J. 2020;19(1):451.CrossRefPubMedPubMedCentral Galatas B, Mayor A, Gupta H, Balanza N, Jang IK, Nhamussua L, Simone W, Cistero P, Chidimatembue A, Munguambe H, et al. Field performance of ultrasensitive and conventional malaria rapid diagnostic tests in southern Mozambique. Malar J. 2020;19(1):451.CrossRefPubMedPubMedCentral
16.
go back to reference Mayor A, Bardaji A, Macete E, Nhampossa T, Fonseca AM, Gonzalez R, Maculuve S, Cistero P, Ruperez M, Campo J, et al. Changing trends in P. falciparum burden, immunity, and disease in pregnancy. N Engl J Med. 2015;373(17):1607–17.CrossRefPubMed Mayor A, Bardaji A, Macete E, Nhampossa T, Fonseca AM, Gonzalez R, Maculuve S, Cistero P, Ruperez M, Campo J, et al. Changing trends in P. falciparum burden, immunity, and disease in pregnancy. N Engl J Med. 2015;373(17):1607–17.CrossRefPubMed
17.
go back to reference Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10:e62997. Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10:e62997.
18.
go back to reference Galinsky K, Valim C, Salmier A, de Thoisy B, Musset L, Legrand E, Faust A, Baniecki ML, Ndiaye D, Daniels RF, et al. COIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism data. Malar J. 2015;14:4.CrossRefPubMedPubMedCentral Galinsky K, Valim C, Salmier A, de Thoisy B, Musset L, Legrand E, Faust A, Baniecki ML, Ndiaye D, Daniels RF, et al. COIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism data. Malar J. 2015;14:4.CrossRefPubMedPubMedCentral
19.
go back to reference Fonseca AM, Gonzalez R, Bardaji A, Jairoce C, Ruperez M, Jimenez A, Quinto L, Cistero P, Vala A, Sacoor C, et al. VAR2CSA serology to detect Plasmodium falciparum transmission patterns in pregnancy. Emerg Infect Dis. 2019;25(10):1851–60.CrossRefPubMedPubMedCentral Fonseca AM, Gonzalez R, Bardaji A, Jairoce C, Ruperez M, Jimenez A, Quinto L, Cistero P, Vala A, Sacoor C, et al. VAR2CSA serology to detect Plasmodium falciparum transmission patterns in pregnancy. Emerg Infect Dis. 2019;25(10):1851–60.CrossRefPubMedPubMedCentral
20.
go back to reference Chene A, Gangnard S, Dechavanne C, Dechavanne S, Srivastava A, Tetard M, Hundt S, Leroy O, Havelange N, Viebig NK, et al. Down-selection of the VAR2CSA DBL1–2 expressed in E. coli as a lead antigen for placental malaria vaccine development. NPJ Vaccines. 2018;3:28.CrossRefPubMedPubMedCentral Chene A, Gangnard S, Dechavanne C, Dechavanne S, Srivastava A, Tetard M, Hundt S, Leroy O, Havelange N, Viebig NK, et al. Down-selection of the VAR2CSA DBL1–2 expressed in E. coli as a lead antigen for placental malaria vaccine development. NPJ Vaccines. 2018;3:28.CrossRefPubMedPubMedCentral
21.
go back to reference Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Bioprocess Biosyst Eng. 2010;33(6):719–30.CrossRefPubMed Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Bioprocess Biosyst Eng. 2010;33(6):719–30.CrossRefPubMed
22.
go back to reference Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol. 2002;123(1):23–33.CrossRefPubMed Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol. 2002;123(1):23–33.CrossRefPubMed
23.
go back to reference Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, Chitnis CE, Gaur D. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS ONE. 2011;6(2):e17102.CrossRefPubMedPubMedCentral Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, Chitnis CE, Gaur D. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS ONE. 2011;6(2):e17102.CrossRefPubMedPubMedCentral
24.
go back to reference Reddy KS, Pandey AK, Singh H, Sahar T, Emmanuel A, Chitnis CE, Chauhan VS, Gaur D. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies. Infect Immun. 2014;82(1):152–64.CrossRefPubMedPubMedCentral Reddy KS, Pandey AK, Singh H, Sahar T, Emmanuel A, Chitnis CE, Chauhan VS, Gaur D. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies. Infect Immun. 2014;82(1):152–64.CrossRefPubMedPubMedCentral
25.
go back to reference Helb DA, Tetteh KK, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, Mayanja-Kizza H, Ssewanyana I, Kamya MR, Beeson JG, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A. 2015;112(32):E4438-4447.CrossRefPubMedPubMedCentral Helb DA, Tetteh KK, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, Mayanja-Kizza H, Ssewanyana I, Kamya MR, Beeson JG, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A. 2015;112(32):E4438-4447.CrossRefPubMedPubMedCentral
26.
go back to reference Taylor SM, Mayor A, Mombo-Ngoma G, Kenguele HM, Ouedraogo S, Ndam NT, Mkali H, Mwangoka G, Valecha N, Singh JP, et al. A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species. J Clin Microbiol. 2014;52(6):2144–9.CrossRefPubMedPubMedCentral Taylor SM, Mayor A, Mombo-Ngoma G, Kenguele HM, Ouedraogo S, Ndam NT, Mkali H, Mwangoka G, Valecha N, Singh JP, et al. A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species. J Clin Microbiol. 2014;52(6):2144–9.CrossRefPubMedPubMedCentral
27.
go back to reference Oyola SO, Ariani CV, Hamilton WL, Kekre M, Amenga-Etego LN, Ghansah A, Rutledge GG, Redmond S, Manske M, Jyothi D, et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar J. 2016;15(1):597.CrossRefPubMedPubMedCentral Oyola SO, Ariani CV, Hamilton WL, Kekre M, Amenga-Etego LN, Ghansah A, Rutledge GG, Redmond S, Manske M, Jyothi D, et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar J. 2016;15(1):597.CrossRefPubMedPubMedCentral
29.
go back to reference Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS ONE. 2010;5(8):e12012.CrossRefPubMedPubMedCentral Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS ONE. 2010;5(8):e12012.CrossRefPubMedPubMedCentral
30.
go back to reference Ampomah P, Stevenson L, Ofori MF, Barfod L, Hviid L. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J Immunol. 2014;192(11):5236–44.CrossRefPubMedPubMedCentral Ampomah P, Stevenson L, Ofori MF, Barfod L, Hviid L. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J Immunol. 2014;192(11):5236–44.CrossRefPubMedPubMedCentral
31.
go back to reference Staalsoe T, Megnekou R, Fievet N, Ricke CH, Zornig HD, Leke R, Taylor DW, Deloron P, Hviid L. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis. 2001;184(5):618–26.CrossRefPubMed Staalsoe T, Megnekou R, Fievet N, Ricke CH, Zornig HD, Leke R, Taylor DW, Deloron P, Hviid L. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis. 2001;184(5):618–26.CrossRefPubMed
32.
go back to reference Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833–40.CrossRefPubMed Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833–40.CrossRefPubMed
33.
go back to reference Hendry JA, Kwiatkowski D, McVean G. Elucidating relationships between P.falciparum prevalence and measures of genetic diversity with a combined genetic-epidemiological model of malaria. PLoS Comput Biol. 2021;17(8):e1009287.CrossRefPubMedPubMedCentral Hendry JA, Kwiatkowski D, McVean G. Elucidating relationships between P.falciparum prevalence and measures of genetic diversity with a combined genetic-epidemiological model of malaria. PLoS Comput Biol. 2021;17(8):e1009287.CrossRefPubMedPubMedCentral
34.
go back to reference Walker PGT, Cairns M, Slater H, Gutman J, Kayentao K, Williams JE, Coulibaly SO, Khairallah C, Taylor S, Meshnick SR, et al. Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa. Nat Commun. 2020;11(1):3799.CrossRefPubMedPubMedCentral Walker PGT, Cairns M, Slater H, Gutman J, Kayentao K, Williams JE, Coulibaly SO, Khairallah C, Taylor S, Meshnick SR, et al. Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa. Nat Commun. 2020;11(1):3799.CrossRefPubMedPubMedCentral
35.
go back to reference Goncalves BP, Walker PG, Cairns M, Tiono AB, Bousema T, Drakeley C. Pregnant women: an overlooked asset to Plasmodium falciparum malaria elimination campaigns? Trends Parasitol. 2017;33(7):510–8.CrossRefPubMed Goncalves BP, Walker PG, Cairns M, Tiono AB, Bousema T, Drakeley C. Pregnant women: an overlooked asset to Plasmodium falciparum malaria elimination campaigns? Trends Parasitol. 2017;33(7):510–8.CrossRefPubMed
36.
go back to reference Koepfli C, Ome-Kaius M, Jally S, Malau E, Maripal S, Ginny J, Timinao L, Kattenberg JH, Obadia T, White M, et al. Sustained malaria control over an 8-year period in Papua New Guinea: the challenge of low-density asymptomatic Plasmodium infections. J Infect Dis. 2017;216(11):1434–43.CrossRefPubMedPubMedCentral Koepfli C, Ome-Kaius M, Jally S, Malau E, Maripal S, Ginny J, Timinao L, Kattenberg JH, Obadia T, White M, et al. Sustained malaria control over an 8-year period in Papua New Guinea: the challenge of low-density asymptomatic Plasmodium infections. J Infect Dis. 2017;216(11):1434–43.CrossRefPubMedPubMedCentral
37.
go back to reference Morris U, Xu W, Msellem MI, Schwartz A, Abass A, Shakely D, Cook J, Bhattarai A, Petzold M, Greenhouse B, et al. Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005–2013. Infect Genet Evol. 2015;33:110–7.CrossRefPubMed Morris U, Xu W, Msellem MI, Schwartz A, Abass A, Shakely D, Cook J, Bhattarai A, Petzold M, Greenhouse B, et al. Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005–2013. Infect Genet Evol. 2015;33:110–7.CrossRefPubMed
Metadata
Title
Gravidity and malaria trends interact to modify P. falciparum densities and detectability in pregnancy: a 3-year prospective multi-site observational study
Authors
Glória Matambisso
Nanna Brokhattingen
Sónia Maculuve
Pau Cisteró
Henriques Mbeve
Anna Escoda
Judice Miguel
Elena Buetas
Ianthe de Jong
Boaventura Cuna
Cardoso Melembe
Nelo Ndimande
Gemma Porras
Haily Chen
Kevin K. A. Tetteh
Chris Drakeley
Benoit Gamain
Chetan Chitnis
Virander Chauhan
Llorenç Quintó
Beatriz Galatas
Eusébio Macete
Alfredo Mayor
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Malaria
Published in
BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-022-02597-6

Other articles of this Issue 1/2022

BMC Medicine 1/2022 Go to the issue